 
                        | Product NDC: | 54531-100 | 
| Proprietary Name: | Minocin | 
| Non Proprietary Name: | minocycline hydrochloride | 
| Active Ingredient(s): | 100 mg/1 & nbsp; minocycline hydrochloride | 
| Administration Route(s): | INTRAVENOUS | 
| Dosage Form(s): | INJECTION | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 54531-100 | 
| Labeler Name: | Rempex Pharmaceuticals, Inc. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | NDA050444 | 
| Marketing Category: | NDA | 
| Start Marketing Date: | 20130419 | 
| Package NDC: | 54531-100-01 | 
| Package Description: | 10 INJECTION in 1 CARTON (54531-100-01) | 
| NDC Code | 54531-100-01 | 
| Proprietary Name | Minocin | 
| Package Description | 10 INJECTION in 1 CARTON (54531-100-01) | 
| Product NDC | 54531-100 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | minocycline hydrochloride | 
| Dosage Form Name | INJECTION | 
| Route Name | INTRAVENOUS | 
| Start Marketing Date | 20130419 | 
| Marketing Category Name | NDA | 
| Labeler Name | Rempex Pharmaceuticals, Inc. | 
| Substance Name | MINOCYCLINE HYDROCHLORIDE | 
| Strength Number | 100 | 
| Strength Unit | mg/1 | 
| Pharmaceutical Classes | Tetracycline-class Drug [EPC],Tetracyclines [Chemical/Ingredient] |